BIOMARIN PHARMACEUTICAL INC Common Stock Issued, Employee Trust, Deferred
BIOMARIN PHARMACEUTICAL INC (BMRN) had Common Stock Issued, Employee Trust, Deferred of $14.47 million as of 2017-09-30, per its 10-Q filed 2017-10-31.
Discontinued › Balance Sheet
us-gaap:CommonStockIssuedEmployeeTrustDeferred · last filed 2017-10-31
- 2017-09-30: Common Stock Issued, Employee Trust, Deferred $14.47M.
- 2017-06-30: Common Stock Issued, Employee Trust, Deferred $14.29M.
- 2017-03-31: Common Stock Issued, Employee Trust, Deferred $14.10M.
- 2016-12-31: Common Stock Issued, Employee Trust, Deferred $14.32M.
| Period end | Common Stock Issued, Employee Trust, Deferred |
|---|---|
| 2017-09-30 | $14.47M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $14.29M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $14.10M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $14.32M 10-Q · filed 2017-10-31 |
| 2016-09-30 | $14.97M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $14.97M 10-Q · filed 2016-08-08 |
| 2015-12-31 | $13.62M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |